Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

So, Albert, thank you so much for joining us on this very special day for you at Pfizer. You had your first quarter results out, which were strong and beat estimates. As you look at those results.Why do you think you beat the estimates and what does it tell you about the rest of the year. Well, it's about execution. We were very focused and our commercial investing, which is basically the reflection of these commercial results, is one of a kind.They are very, very good. They understand the customer. They un ...